Business Information
The group's principal activity is to develop, manufacture and market excimer laser and fiber optic systems and techniques. These products are designed for the treatment of psoriasis, vitiligo, atopic dermatitis and leukoderma. The activities are carried out through four segments: domestic xtrac, international xtrac, surgical services and surgical products and other. The group also develops, manufactures and markets proprietary lasers and delivery systems for both contact and non-contact surgery and provides surgical services utilizing these and other manufacturers' products. The customers include doctors, hospitals and surgery centers.
|
|
Name |
Title
|
Email
|
| Richard Depiano | Chmn. | N/A | | Rox Anderson | Chmn. - Scientific Advisory Board | N/A | | Dennis McGrath | CFO, VP - Finance, Administration | N/A | | Jeffrey Levatter | CTO | N/A | | Michael Stewart | COO | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 33,190 | (7,492) | | 2005 | 28,385 | (3,936) | | 2004 | 17,745 | (4,984)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
